European Commission wrong to deny release of von der Leyen messages, court says

The Commission is found to have wrongly refused to publish texts from its president during the Covid pandemic.

Watch LiveBritish Broadcasting CorporationHomeNewsSportBusinessInnovationCultureArtsTravelEarthAudioVideoLiveHomeNewsIsrael-Gaza WarWar in UkraineUS & CanadaUKUK PoliticsEnglandN. IrelandN. Ireland PoliticsScotlandScotland PoliticsWalesWales PoliticsAfricaAsiaChinaIndiaAustraliaEuropeLatin AmericaMiddle EastIn PicturesBBC InDepthBBC VerifySportBusinessExecutive LoungeTechnology of BusinessFuture of BusinessInnovationTechnologyScience & HealthArtificial IntelligenceAI v the MindCultureFilm & TVMusicArt & DesignStyleBooksEntertainment NewsArtsArts in MotionTravelDestinationsAfricaAntarcticaAsiaAustralia and PacificCaribbean & BermudaCentral AmericaEuropeMiddle EastNorth AmericaSouth AmericaWorld’s TableCulture & ExperiencesAdventuresThe SpeciaListEarthNatural WondersWeather & ScienceClimate SolutionsSustainable BusinessGreen LivingAudioPodcastsRadioAudio FAQsVideoLiveLive NewsLive SportHomeNewsSportBusinessInnovationCultureArtsTravelEarthAudioVideoLiveWeatherNewslettersWatch LiveEuropean Commission wrong to deny release of von der Leyen messages, court says1 day agoShareSavePaul KirbyEurope digital editorShareSaveLUDOVIC MARIN/AFPUrsula von der Leyen's text messages with the boss of Pfizer are at the centre of the caseThe European Commission was wrong to refuse to release text messages sent by Ursula von der Leyen to the head of Pfizer during negotiations to secure Covid-19 vaccines, the EU's top court has ruled.

The General Court said the commission had not given a plausible explanation as to why the exchanges between its president and Pfizer's Albert Bourla could not be made public when an investigative journalist requested them in 2021.

That year, Pfizer signed billions of euros in vaccine contracts with the EU, including a deal for 1.8bn extra doses.

The content of the messages between von der Leyen and Mr Bourla remains secret, in a simmering case that has become known in Brussels as Pfizergate.

Anti-corruption group Transparency International has hailed the European Court's ruling as a "landmark victory for transparency in the EU", adding that it should serve as a catalyst to put an end to a "restrictive attitude to freedom of information".